Systemic adverse events following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis: Two patients with dermatologic adverse events and review of the literature
Authors:
- Ruy CarrascoRCRuy Carrasco
- Philip J. HashkesPHPhilip J. Hashkes
- 1 August 2013
- journal article
- case report
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 43 (1) , 71-76
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic featuresArthritis Care & Research, 2011
- Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature reviewRheumatology International, 2010
- Cushing's Syndrome Induced by Misuse of Moderate- to High-Potency Topical CorticosteroidsAnnals of Pharmacotherapy, 2008
- Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoateBritish Journal of Clinical Pharmacology, 2007
- Injectable corticosteroids in treatment of arthritis of the kneeThe American Journal of Medicine, 2005
- Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trialRheumatology, 2004
- Cushing’s Syndrome After Intra-articular and Intradermal Administration of Triamcinolone Acetonide in Three Pediatric PatientsPediatrics, 2004
- Corticosteroids—from an idea to clinical useBest Practice & Research Clinical Rheumatology, 2004
- Growth-Suppressive Effect of Intra-Articular Glucocorticoids Detected by KnemometryHormone Research in Paediatrics, 1999
- Joint calcification following intra-articular corticosteroid therapy.Radiology, 1984